A Study to Assess the Efficacy of Rituximab (MabThera) in First Line Treatment of Chronic Lymphocytic Leukemia (CLL)
Clinical trial NCT00545714 · COMPLETED
Trial details
- NCT number
- NCT00545714
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-21
- Primary completion
- 2016-05-20
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.